| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 1187 |
| 1 | RIBOCICLIB | 1057 |
| 2 | SECUKINUMAB | 880 |
| 3 | LETROZOLE | 575 |
| 4 | METHOTREXATE SODIUM | 561 |
| 5 | NATALIZUMAB | 529 |
| 6 | PALBOCICLIB | 485 |
| 7 | METHOTREXATE | 456 |
| 8 | FULVESTRANT | 426 |
| 9 | LETROZOLE TABLETS | 401 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RIBOCICLIB | 1057 | 0.0323 |
| 1 | PSYLLIUM HUSK | 35 | 0.0259 |
| 2 | MENADIONE | 3 | 0.0216 |
| 3 | GOLIMUMAB | 217 | 0.0172 |
| 4 | FULVESTRANT | 426 | 0.0127 |
| 5 | PHENAZOPYRIDINE HYDROCHLORIDE | 4 | 0.0121 |
| 6 | ANASTROZOLE TABLETS | 257 | 0.0117 |
| 7 | ERGOCALCIFEROL | 329 | 0.0111 |
| 8 | NORTRIPTYLINE HYDROCHLORIDE | 61 | 0.0102 |
| 9 | INFLIXIMAB-DYYB | 35 | 0.0102 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1756 |
| 1 | Interleukin-17A Antagonist [EPC] | 918 |
| 2 | Aromatase Inhibitor [EPC] | 883 |
| 3 | Kinase Inhibitor [EPC] | 861 |
| 4 | Corticosteroid [EPC] | 797 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 666 |
| 6 | Integrin Receptor Antagonist [EPC] | 664 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 461 |
| 8 | Vitamin C [EPC] | 442 |
| 9 | Estrogen Receptor Antagonist [EPC] | 426 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 28 | 0.0407 |
| 1 | Interleukin-17A Antagonist [EPC] | 918 | 0.0246 |
| 2 | Polymyxin-class Antibacterial [EPC] | 1 | 0.0137 |
| 3 | Provitamin D2 Compound [EPC] | 329 | 0.0111 |
| 4 | Estrogen Receptor Antagonist [EPC] | 426 | 0.0105 |
| 5 | Aromatase Inhibitor [EPC] | 883 | 0.0078 |
| 6 | Integrin Receptor Antagonist [EPC] | 664 | 0.0076 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 32 | 0.0055 |
| 8 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 67 | 0.0048 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 9 | 0.0043 |